AUPH - Aurinia Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AUPH is currently covered by 5 analysts with an average price target of $17.15. This is a potential upside of $8.96 (109.4%) from yesterday's end of day stock price of $8.19.

Aurinia Pharmaceuticals's activity chart (see below) currently has 90 price targets and 61 ratings on display. The stock rating distribution of AUPH is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.33% with an average time for these price targets to be met of 414 days.

Highest price target for AUPH is $13, Lowest price target is $13, average price target is $9.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 05-Sep-2024. First documented stock forecast 29-Jun-2016.

Currently out of the existing stock ratings of AUPH, 10 are a BUY (83.33%), 2 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$4.81 (58.73%)

$13

9 months 3 days ago
(05-Sep-2024)

10/22 (45.45%)

$5.74 (79.06%)

579

Hold

$6

$-2.19 (-26.74%)

$26

1 years 1 months 7 days ago
(01-May-2024)

3/3 (100%)

$0.83 (16.05%)

398

Buy

$8

$-0.19 (-2.32%)

$11

1 years 3 months 24 days ago
(15-Feb-2024)

8/12 (66.67%)

$2.15 (36.75%)

152

Hold

$13

2 years 7 months 5 days ago
(03-Nov-2022)

5/9 (55.56%)

$4.73 (57.19%)

203

Buy

$12

$3.81 (46.52%)

$22

2 years 7 months 5 days ago
(03-Nov-2022)

1/4 (25%)

$6.85 (133.01%)

266

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AUPH (Aurinia Pharmaceuticals) average time for price targets to be met?

On average it took 414 days on average for the stock forecasts to be realized with a an average price target met ratio 65.33

Which analyst has the current highest performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?

ALETHIA YOUNG

Which analyst has the current lower performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?

KEN CACCIATORE

Which analyst has the most public recommendations on AUPH (Aurinia Pharmaceuticals)?

Alethia Young works at CANTOR FITZGERALD and has 5 price targets and 5 ratings on AUPH

Which analyst is the currently most bullish on AUPH (Aurinia Pharmaceuticals)?

Ken Cacciatore with highest potential upside - $27.23

Which analyst is the currently most reserved on AUPH (Aurinia Pharmaceuticals)?

Maury Raycroft with lowest potential downside - -$2.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?